© Reuters.
EDMONTON, AB – Aurora Cannabis Inc (TSX:). (NASDAQ: NASDAQ:) (: ACB), a prominent player in the global medical cannabis market, has announced a new partnership with Script Assist, a UK-based medical cannabis prescription platform. This collaboration aims to enhance patient access to medical cannabis and provide comprehensive guidance throughout their treatment journey.
The Script Assist platform is designed to facilitate the prescription process for UK patients, offering a range of medical cannabis products from Aurora’s portfolio. In March, the platform will expand its offerings to include three new flower products from Aurora’s EU GMP-certified facilities in Canada. These products are Pedanios 26/1 EHD-CA (Electric Honey Dew), Pedanios 28/1 CMK-CA (Chemango Kush), and Pedanios 10/10 EQI-CA (Equiposa), featuring varying levels of THC and CBD.
Trisha Cassidy, Managing Director of Aurora UK & Ireland, emphasized…
